Last reviewed · How we verify
NCT03878680: ISAAC-UAE
Prevalence of Asthma and Allergies Among Children in UAE
trial testing Study questionnaires in Asthma in 3,737 participants. Completed in 26 June 2019.
26 June 2019
Quick facts
| Lead sponsor | AstraZeneca |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 3,737 |
| Start date | 30 April 2019 |
| Primary completion | 26 June 2019 |
| Estimated completion | 26 June 2019 |
| Sites | 6 locations across United Arab Emirates |
Drugs / interventions tested
- Study questionnaires
Conditions studied
- Asthma — all drugs for Asthma →
Sponsor
AstraZeneca — full company profile →
Who can join
Eligibility, any sex, with Asthma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Multicenter, cross-sectional study to recruit a random sample of 6000 children via school class registers: 3000 children aged 13-14 years and 3000 children aged 6-7 years.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Prevalence of asthma and allergies among children in the United Arab Emirates: A cross-sectional study.
Ibrahim NM, Almarzouqi FI, Al Melaih FA, Farouk H, et al · · 2021 · cited 21× · PMID 34703522 · DOI 10.1016/j.waojou.2021.100588
Verify or expand the search:
- PubMed search for NCT03878680
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Study questionnaires
Trials testing the same drug.
- NCT06816459 — Sensory Tests of Cigarettes for Identification of Flavors in Current Daily Smoking Adults · EARLY_PHASE1 · recruiting
- NCT03178331 — Who Benefit From School Doctors' Health Checks? · completed
Other recruiting trials for Asthma
Currently open trials in the same condition.
- NCT07525375 — A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared t · Phase 2 · recruiting
- NCT07536256 — Community Connections Through Native Hawaiian Cultural Values to Strengthen Youth Resilience, Health, and Well-Being · NA · recruiting
- NCT07556159 — A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice · recruiting
- NCT07282886 — VENTURI (VENTilation Using Respiratory Imaging) · Phase 2 · recruiting
- NCT07433569 — A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Differ · Phase 1 · recruiting
Other AstraZeneca trials
Trials by the same sponsor.
- NCT06998095 — Tezepelumab (Tezspire) Regulatory Postmarketing Surveillance in Korea · not yet recruiting
- NCT07431775 — Saphnelo Use in Females of Child-bearing Potential · not yet recruiting
- NCT07516184 — Explore the Diagnostic Value of Bronchodilation Test With Portable Oscillometry in Asthma Diagnosis · NA · not yet recruiting
- NCT07279935 — Osimertinib Combined With Chemotherapy in Patients Who Had Distant Recurrence After Adjuvant Osimertinib for EGFRm Resec · Phase 4 · not yet recruiting
- NCT07279948 — A Single-arm Observational Study to Characterize the Demographic, Clinical Features and Outcomes of a Brazilian Cohort o · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03878680 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by AstraZeneca
- Last refreshed: 17 July 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03878680.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing